Oncology & Cancer

New strategy for safer CAR T cell therapy in lymphomas

In treating aggressive lymphomas and blood cancer (leukemia), chimeric antigen receptor T cells (CAR T cells) are increasingly being used. For this therapy, immune cells are taken from patients and programmed by means of ...

page 3 from 40